The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy

@article{Sindrup1992TheSS,
  title={The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy},
  author={S{\o}ren H Sindrup and Ulla Bjerre and Anders Dejgaard and Kim Br{\o}sen and Tove Aaes-J{\o}rgensen and Lennart Gram},
  journal={Clinical Pharmacology \& Therapeutics},
  year={1992},
  volume={52}
}
The effect of the selective serotonin reuptake inhibitor citalopram on diabetic neuropathy symptoms was examined in a double‐blind, placebo‐controlled, crossover study for two 3‐week periods. Citalopram was given as a fixed dose of 40 mg/day. Data from 15 patients could be included in the statistical analysis. Citalopram significantly relieved the symptoms of neuropathy as measured by both observer‐ and self‐rating in comparison with placebo. The steady‐state plasma concentration of citalopram… 
A randomized controlled trial of citalopram in the treatment of fibromyalgia
TLDR
The strength of the study was sufficient to exclude an effect of citalopram of more than 1 steps of 10 on the categoric scales for pain, fatigue and general condition (95% confidence limit), which indicates that the sample size was sufficiently large.
A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache.
TLDR
Although amitriptyline did not eliminate the headache, it provided a clinically important reduction of headache in the majority of otherwise treatment resistant patients, indicating that mechanisms other than inhibition of serotonin reuptake are involved in the analgesic effect of the tricyclic antidepressants.
Patient Compliance With SSRIs and Gabapentin in Painful Diabetic Neuropathy
TLDR
The lack of negative effects on quality of life, the better compliance, and the comparable efficiency of SSRIs suggest that these drugs may be considered as alternative to gabapentin in painful diabetic neuropathy.
Randomized controlled trial of the combined monoaminergic and opioid investigational compound GRT9906 in painful polyneuropathy
TLDR
In this randomized, double‐blind, placebo‐controlled, three‐way cross‐over trial in painful polyneuropathy, GRT9906 demonstrated analgesic efficacy with a magnitude of effect comparable with tramadol and was well tolerated.
The Efficacy of Selective Serotonin Reuptake Inhibitors for the Management of Chronic Pain
TLDR
It is unclear, from the available evidence, whether SSRIs are beneficial for migraine headaches, tension headaches, diabetic neuropathy, or fibromyalgia, but it may be reasonable to reserve SSR is for those who fail to respond to other medications or who are intolerant of their side effects.
The Efficacy of Selective Serotonin Reuptake Inhibitors for the Management of Chronic Pain
TLDR
It is unclear, from the available evidence, whether SSRIs are beneficial for migraine headaches, tension headaches, diabetic neuropathy, or fibromyalgia, but it may be reasonable to reserve SSR is for those who fall to respond to other medications or who are intolerant of their side effects.
Venlafaxine versus imipramine in painful polyneuropathy
TLDR
Venlafaxine relieves pain in polyneuropathy and may be as effective as imipramine.
Safety and Efficacy of s-Citalopram in Patients with Co-Morbid Major Depression and Diabetes Mellitus
TLDR
A significant reduction in depressive symptoms and modest, non-significant reductions in fasting glucose, fructosamine, and glycosylated hemoglobin-A1C levels during SSRI therapy of co-morbid depression and diabetes are observed.
Comparrative Assay of Citalopram in Different Media
Citalopram is one of a class of antidepressants known as selective serotonin reuptake inhibitors. Citalopram blocks the reuptake of serotonin at the serotonin reuptake pump of the neuronal membrane,
Pharmacologic treatment of pain in polyneuropathy
TLDR
Tricyclic antidepressants are at the moment still the drugs of first choice, and drugs such as gabapentin, carbamazepine, and tramadol may be tried if contraindications or tolerability problems are encountered with the tricyclics.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 32 REFERENCES
The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms
TLDR
40 mg paroxetine/day significantly reduced the symptoms in peripheral diabetic neuropathy and it was suggested that by dose adjustment on the basis of drug level monitoring, parxetine may become as effective as imipramine.
Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy.
TLDR
Desipramine relieves pain caused by diabetic neuropathy with efficacy similar to that of amitriptyline, offering an alternative for patients unable to tolerate the latter and blockade of norepinephrine reuptake is likely to mediate the analgesic effect of these antidepressant drugs in diabetic Neuropathy.
Concentration‐response relationship in imipramine treatment of diabetic neuropathy symptoms
TLDR
The dose‐dependent kinetics of imipramine was confirmed, and dose increments should be carried out in small steps and preferably with monitoring of drug levels, and the effect of treatment was evaluated by use of visual analog scales.
Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study.
TLDR
Compared with earlier results obtained with imipramine dosed on the basis of plasma level monitoring, clomipramines on fixed doses appeared less efficacious whereas the side effect profiles were the same.
Pain Relief in Diabetic Neuropathy: The Effectiveness of Imipramine and Related Drugs
  • R. Young, B. Clarke
  • Medicine
    Diabetic medicine : a journal of the British Diabetic Association
  • 1985
TLDR
Experience of treating 80 consecutive patients with painful diabetic neuropathy and a double‐blind study of imipramine in acute painful neuropathy are reported, suggesting a peripheral rather than central drug action.
[Mexiletine in treatment of painful diabetic neuropathy].
TLDR
There is strong evidence that particularly patients with stabbing or burning pain, heat sensations or formication will benefit most by mexiletine therapy, and a medium regimen of 450 mg per day seems to be appropriate in this indication.
Hypoalgesia induced by antidepressants in mice: a case for opioids and serotonin.
TLDR
It was concluded on the basis of these findings that short-chain opioids and 5-HT appear to have a role in the hypoalgesic effect of either classical or atypical AD.
Cardiovascular and psychomotor effects of repeated doses of paroxetine: a comparison with amitriptyline and placebo in healthy men
TLDR
Paroxetine was given at a dose of 30mg nightly for the full 14 days, while the dose of amitriptyline was increased from 25mg nightly on day 1 to 15Omg weekly on day 5; this dose was maintained for the remainder of the 14-day study.
Possible involvement of opiate receptors in the pharmacological profiles of antidepressant compounds.
TLDR
The relative potency of the tricyclic antidepressants with regard to inhibitions of opiate binding in brain did not correlate with their clinical efficiency as antidepressants, suggesting that these compounds probably do not exert their antidepressant effects through opioid peptidergic systems in brain.
Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood
TLDR
It is concluded that amitriptyline relieves pain in diabetic neuropathy; this effect is independent of mood elevation.
...
1
2
3
4
...